247 related articles for article (PubMed ID: 23042745)
1. Association of CD1a-positive dendritic cells with papillary thyroid carcinoma in thyroid fine-needle aspirations: a cytologic and immunocytochemical evaluation.
Pusztaszeri MP; Sadow PM; Faquin WC
Cancer Cytopathol; 2013 Apr; 121(4):206-13. PubMed ID: 23042745
[TBL] [Abstract][Full Text] [Related]
2. CD117: a novel ancillary marker for papillary thyroid carcinoma in fine-needle aspiration biopsies.
Pusztaszeri MP; Sadow PM; Faquin WC
Cancer Cytopathol; 2014 Aug; 122(8):596-603. PubMed ID: 24920192
[TBL] [Abstract][Full Text] [Related]
3. BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.
Ohori NP; Singhal R; Nikiforova MN; Yip L; Schoedel KE; Coyne C; McCoy KL; LeBeau SO; Hodak SP; Carty SE; Nikiforov YE
Cancer Cytopathol; 2013 Apr; 121(4):197-205. PubMed ID: 22887810
[TBL] [Abstract][Full Text] [Related]
4. Papillary thyroid carcinoma with atypical histiocytoid cells on fine-needle aspiration.
Harshan M; Crapanzano JP; Aslan DL; Vazquez MF; Saqi A
Diagn Cytopathol; 2009 Apr; 37(4):244-50. PubMed ID: 19217032
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing tall cell variant of papillary thyroid carcinoma from usual variant of papillary thyroid carcinoma in cytologic specimens.
Solomon A; Gupta PK; LiVolsi VA; Baloch ZW
Diagn Cytopathol; 2002 Sep; 27(3):143-8. PubMed ID: 12203860
[TBL] [Abstract][Full Text] [Related]
6. Fine-needle aspirations of papillary carcinoma with oncocytic features: an expanded cytologic and histologic profile.
Renshaw AA
Cancer Cytopathol; 2011 Aug; 119(4):247-53. PubMed ID: 21400667
[TBL] [Abstract][Full Text] [Related]
7. FNAB of benign thyroid nodules with papillary hyperplasia: a cytological and histological evaluation.
Pusztaszeri MP; Krane JF; Cibas ES; Daniels G; Faquin WC
Cancer Cytopathol; 2014 Sep; 122(9):666-77. PubMed ID: 24891128
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of dendritic/Langerhans cells in thyroid carcinomas.
Yamakawa M; Yamada K; Orui H; Tsuge T; Ogata T; Dobashi M; Imai Y
Anal Cell Pathol; 1995 Jun; 8(4):331-43. PubMed ID: 7577748
[TBL] [Abstract][Full Text] [Related]
9. Galectin-3 is not useful in thyroid FNA.
Mills LJ; Poller DN; Yiangou C
Cytopathology; 2005 Jun; 16(3):132-8. PubMed ID: 15924608
[TBL] [Abstract][Full Text] [Related]
10. Histiocytic aggregates in benign nodular goiters mimicking cytologic features of papillary thyroid carcinoma (PTC).
Nassar A; Gupta P; LiVolsi VA; Baloch Z
Diagn Cytopathol; 2003 Nov; 29(5):243-5. PubMed ID: 14595788
[TBL] [Abstract][Full Text] [Related]
11. CD1a-positive dendritic cell density predicts disease-free survival in papillary thyroid carcinoma.
Hilly O; Rath-Wolfson L; Koren R; Mizrachi A; Hamzany Y; Bachar G; Shpitzer T
Pathol Res Pract; 2015 Sep; 211(9):652-6. PubMed ID: 26073685
[TBL] [Abstract][Full Text] [Related]
12. Characterization of dendritic cells in differentiated thyroid cancer.
Tsuge K; Takeda H; Kawada S; Maeda K; Yamakawa M
J Pathol; 2005 Apr; 205(5):565-76. PubMed ID: 15714595
[TBL] [Abstract][Full Text] [Related]
13. "Atypical" cells in fine-needle aspiration biopsy specimens of benign thyroid cysts.
Faquin WC; Cibas ES; Renshaw AA
Cancer; 2005 Apr; 105(2):71-9. PubMed ID: 15662703
[TBL] [Abstract][Full Text] [Related]
14. Nodule heterogeneity as shown by size differences between the targeted nodule and the tumor in thyroidectomy specimen: a cause for a false-negative diagnosis of papillary thyroid carcinoma on fine-needle aspiration.
Siddiqui MA; Griffith KA; Michael CW; Pu RT
Cancer; 2008 Feb; 114(1):27-33. PubMed ID: 18085634
[TBL] [Abstract][Full Text] [Related]
15. [Expression and clinical significance of CD1a+ dendritic cells in glottic squamous cell carcinoma].
Chen WK; Chen FJ; Zeng ZY; Wu GH; Guo ZM; Wei MW; Yang AK; Zhang Q; He JH; Hou JH
Ai Zheng; 2005 Sep; 24(9):1124-6. PubMed ID: 16159438
[TBL] [Abstract][Full Text] [Related]
16. Can cytomorphology differentiate between benign nodules and tumors arising in Graves' disease?
Anderson SR; Mandel S; LiVolsi VA; Gupta PK; Baloch ZW
Diagn Cytopathol; 2004 Jul; 31(1):64-7. PubMed ID: 15236269
[TBL] [Abstract][Full Text] [Related]
17. Selective expression of CD44 cell-adhesion molecule in thyroid papillary carcinoma fine-needle aspirates.
Ross JS; del Rosario AD; Sanderson B; Bui HX
Diagn Cytopathol; 1996 Jun; 14(4):287-91. PubMed ID: 8725126
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical evaluation of thyroid neoplasms on thin-layer smears from fine-needle aspiration biopsies.
Rossi ED; Raffaelli M; Minimo C; Mule A; Lombardi CP; Vecchio FM; Fadda G
Cancer; 2005 Apr; 105(2):87-95. PubMed ID: 15742329
[TBL] [Abstract][Full Text] [Related]
19. Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells.
Scarpino S; Stoppacciaro A; Ballerini F; Marchesi M; Prat M; Stella MC; Sozzani S; Allavena P; Mantovani A; Ruco LP
Am J Pathol; 2000 Mar; 156(3):831-7. PubMed ID: 10702399
[TBL] [Abstract][Full Text] [Related]
20. Expression of Bax, p53, and p27/kip in patients with papillary thyroid carcinoma with or without cervical nodal metastasis.
Karlidag T; Cobanoglu B; Keles E; Alpay HC; Ozercan I; Kaygusuz I; Yalcin S; Sakallioglu O
Am J Otolaryngol; 2007; 28(1):31-6. PubMed ID: 17162129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
